I

Incyte

Biopharmaceutical company pursuing drug discovery.

Digital Transformation & Process Excellence Intern

Supply Chain ManagementPosted on Nov 12
InternshipMorges, SwitzerlandNo salary listedIn-person

About the Job

Requirements

  • Currently pursuing or recently completed studies in Supply Chain Management, Life Sciences, Pharmaceutical Sciences, Data Analytics, Business Analytics, Digital Transformation, or Industrial Engineering.
  • Preferred technical skills include Microsoft Power BI, advanced Excel, Microsoft Power Platform, SharePoint, Microsoft Teams, Microsoft Planner, process mapping, data analytics, and dashboard development.
  • The candidate should have an analytical mindset, curiosity and creativity, communication skills, autonomy and proactivity, structured problem-solving ability, and the ability to work across functions.

Responsibilities

  • Identify opportunities to simplify and digitalize existing processes, reduce manual administrative work, improve visibility of critical operational data, standardize governance and reporting practices, support automation solutions, and deliver practical digital tools.
  • Support development of an External Manufacturing KPI dashboard by mapping KPI sources, gathering stakeholder reporting requirements, creating KPI definitions and governance, supporting Power BI dashboard development, designing CMO performance scorecards and executive reporting views, and creating user documentation.
  • Support implementation of a standardized Microsoft Planner approach for Product Stewards and CMO teams by assessing action tracking, creating templates, defining categories and workflows, building management reporting views, developing training materials, and supporting a pilot.
  • Support harmonization of Product Steward reporting and governance by reviewing meeting processes, benchmarking reporting approaches, developing templates, creating automated reporting, building risk and decision trackers, and supporting governance standards.
  • Support development of a predictive supply chain and material movement visibility tool by mapping end-to-end flows, identifying planning milestones, analyzing operational data, defining predictive indicators, designing dashboards, and developing business requirements for automation.
  • Assess automation opportunities for Supply Chain Notification creation in Veeva by mapping processes, identifying manual activities, quantifying effort and bottlenecks, evaluating automation, developing a business case for RPA or bot implementation, and preparing process documentation.
  • Support modernization of CMO Business Review Meetings through Power BI, SharePoint, Microsoft Planner, and PowerPoint integration by analyzing preparation processes, standardizing presentations, creating automated KPI visualizations, integrating action tracking, implementing digital repositories, and designing performance scorecards.
  • Support transition from paper-based to electronic workflows for quarantine shipments by documenting current processes, identifying digitalization opportunities, supporting workflow design, gathering user requirements, creating process documentation, and developing training materials.
  • Facilitate stakeholder workshops, support change management, prepare management presentations, develop project dashboards, track project progress and KPIs, present recommendations to leadership, and identify further digitalization opportunities.

Desired Qualifications

  • Preferred skills include Microsoft Power BI, advanced Excel, Microsoft Power Platform, SharePoint, Microsoft Teams, Microsoft Planner, process mapping, data analytics, and dashboard development.
  • The candidate should have an analytical mindset, curiosity and creativity, communication skills, autonomy and proactivity, structured problem-solving ability, and the ability to work across functions.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs